En Es
Categories

Industry News

MEDICA 2018 Launches App Competition for Smart Products

By HospiMedica International staff writers
11 Jun 2018

Image: The MEDICA competition is designed for applications for smart phones, smart watches, tablets or AR/VR glasses (Photo courtesy of iStock).The search for the best health app solutions in the world has begun with the launch of the seventh MEDICA App Competition. The competition is meant for applications for smart phones, smart watches, tablets or AR/VR glasses, but excludes fitness or wellness applications. All submitted applications for the MEDICA App Competition 2018 must have a connection with professional medical technology, and applications from start-ups that are still in the early stage are also invited.

Last year’s winner was iSikCure, an application that allows patients to communicate with their doctors, laboratories, chemists and other suppliers in the healthcare arena through a smart phone. For instance, the application allows users to make payments, obtain second opinions and verify a supplier’s reputation. iSikCure also allows payment via M-Pesa, a smart phone currency for carrying out basic transactions such as money transfers and cashless payments through a smart phone without the need to access to a regular bank account. The Air Smart Spirometer project, which is the first spirometer linked to a smart phone, came in second at the MEDICA App competition 2017, while the third place was taken by the application Kaia which brings multi-disciplinary therapies for back pain that are in line with directives into the digital world.

The jury of experts for the MEDICA App Competition will go through all the submissions to select 10 start-ups to compete in the live pitch that is scheduled to take place during the MEDICA 2018 to be held in Düsseldorf from November 12-15, 2018. The finalists will present their applications on the MEDICA connected healthcare forum stage at the event on November 14. This first place winner in this year’s MEDICA App competition will be awarded 2,000 euros and the second place winner will receive 1,000 euros, while the third place winner will be given 500 euros. Developers can submit their app creations via the web portal http://www.medica-tradefair.com/mac2 hosted by MEDICA.

Applications that are well thought out overall solutions for the day-to-day use of patients, doctors and clinics stand a better chance of winning. “A drone that delivers medical products and can be controlled via smart phone, for example, is a possible award-winning solution,” said organizer Mark Wächter.

Related Links:
MEDICA



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

12 Jun 2018
AI Software Platform Aims to Synthesize Biomedical Knowledge
nference, which focuses on artificial intelligence (AI)-powered life sciences, is developing an AI software platform to synthesize the exponentially growing biomedical knowledge.
Read More
07 Jun 2018
New AI Algorithm Makes Liver Cancer Surgery Safer
Researchers at the Fraunhofer Institute for Medical Image Computing MEVIS have developed algorithms that analyze patients’ imaging data and calculate surgical risks, making liver cancer surgery safer and easier to plan. Researchers at Fraunhofer have been working on image-processing algorithms for use in medicine since 1998. The method is now widely known among physicians as MEVIS analysis and has become established in practice.
Read More
07 Jun 2018
AI-based Interpretation Tool Receives CE Certification
qXR, an AI-based chest X-ray interpretation tool that detects 15 of the most common chest X-ray abnormalities with an accuracy of more than 90%, has received CE certification. Developed by healthcare AI start-up Qure.ai, qXR has been trained on more than one million chest X-rays and uses a heat map or bounding box to point out abnormalities to the clinician, aiding rapid con?rmation in just milliseconds.
Read More
07 Jun 2018
Global Radiation Detection Market to Reach USD 2 Billion by 2022
The global radiation detection, monitoring, and safety market is expected to grow at a CAGR of 5.7% from USD 1.71 billion in 2017 to USD 2.26 billion by 2022. The market is likely to be driven by rising security threats, increasing prevalence of cancer across the world, growing safety awareness among people working in radiation-prone environments, rising safety concerns following the Fukushima disaster, expanding security budgets of global sporting events, increase in the number of PET/CT scans, growing usage of nuclear medicine and radiation therapy for diagnosis and treatment, and use of drones for radiation monitoring. However, nuclear energy alternatives such as renewable energy, nuclear power phase-out, and shortage of nuclear power workforce, are likely to limit the market growth.
Read More
06 Jun 2018
Siemens Healthineers and ScreenPoint Medical to Develop AI-Based Apps
Siemens Healthineers and ScreenPoint Medical have entered into a partnership to develop artificial intelligence (AI)-based applications for breast imaging. As part of the arrangement, Siemens Healthineers will also acquire a strategic minority stake in ScreenPoint Medical.
Read More
06 Jun 2018
Qure.ai Partners with Teleradiology Solutions for Smarter Diagnoses
Healthcare artificial intelligence (AI) provider, Qure.ai has partnered with Teleradiology Solutions and Telerad Tech to enable smarter and faster diagnoses of X-ray and CT scan data, and reduce costs.
Read More
06 Jun 2018
Algorithms to Enhance Approach for Detecting Tumors
Case Western Reserve University has entered into a collaboration with the Quantum team at Microsoft to use the power of quantum computing for improving patient care. CWRU will use Microsoft’s quantum-inspired algorithms to enhance their approach to detecting cancerous tumors.
Read More
31 May 2018
CerTest Biotec Opens New Facility for Diagnostic Products
CerTest Biotec, a biotechnology company focused on the development and manufacturing of IVD diagnostic products, has opened a new facility in Spain for the research, development and manufacture of molecular diagnostics products.
Read More
31 May 2018
Global Molecular Diagnostics Market to Reach USD 11 Billion by 2023
The global molecular diagnostics market is expected to grow at a CAGR of 8.4% from USD 7.71 billion in 2018 to USD 11.54 billion by 2023, driven by the increasing prevalence of infectious diseases and various types of cancers, rising awareness and acceptance of personalized medicine and companion diagnostics, growth of the biomarker identification market, and advancements in molecular techniques.
Read More
Copyright © 2000-2018 TradeMed.com. All rights reserved. | Terms And Conditions